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Mineralocorticoid Receptor (MR) activation induces the expression of
Neutrophil Gelatinase-Associated Lipocalin (NGAL) in dendritic cells
in vitro and during the aldosterone-dependent hypertension
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Introduction: Inadequate activation of the Mineralocorticoid Receptor
(MR) promotes hypertension, inflammation and fibrosis. Neutrophil Gelati-
nase-Associated Lipocalin (NGAL), a pro-inflammatory/fibrotic glycoprotein,
is a target of MR-genomic upregulation in cardiovascular cells, and is
increased in immune cells during inflammation. Recently, we have demon-
strated that NGAL is crucial for hypertensive effects of aldosterone-salt
(NAS) challenge in mice. The specific cell types that modulate the NGAL
production during Aldosterone (Aldo)-dependent hypertension are unknown.
The aim was to characterize the NGAL expression in mouse immune cells,
and to study the effect of MR activation on the NGAL and pro-inflammatory
cytokines expression in dendritic cells (DCs).
Methods: Male C57Bl6 mice were treated in groups Sham and NAS
(200μg/kg/d, 28 days). Peripheral blood mononuclear cells (PBMC) were iso-
lated, and CD4+, CD8+ T cells, B cells, DCs and Macrophages (Mø) were
sorted from spleen. DCs and Mø were cultured from WT and NGAL-KO mice
and treated with Aldo (100nM) or vehicle for 24hrs. NGAL and cytokines
mRNAs abundance was measured by qRT-PCR.
Results: NAS mice presented high systolic blood pressure (123 mmHg vs.
Sham 101±6 mmHg, p<0.05), cardiac and renal hypertrophy. Additionally,
NAS treatment induced a selective increase in the recruitment of activated-
CD8+ cells, B cells and granulocytes in lymph nodes. NGAL abundance was
higher in PBMC, DCs and Mø, which were further increased in NAS mice
(<3-fold vs. Sham, p<0.05 mRNA). In vitro MR activation by Aldo in DCs,
but not in Mø, induced an upregulation of NGAL and of cytokines involved
in the adaptive immune response: TGF-β1 and IL-23p19 (n=4, p<0.05). Inter-
estingly, the NGAL absence in DCs prevented this overexpression.
Conclusion: The MR activation and their subsequent NGAL induction in
DCs could play a pivotal role in the inflammation observed during the Aldo-
dependent hypertension.
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Background: High blood pressure is one of the most important modifiable
risk factors for cardiovascular disease; the prevalence of hypertension in
Moroccan population is 33.6% 
Hypertension is a complex, multifactorial and may be triggered by the
genetic and environmental factors.
The heritable component of blood pressure has been documented in familial
and twin studies suggesting that 30%-50% of the variance of blood pressure
readings are attributable to genetic heritability and also to environmental fac-
tors.
Methods: A total of 101 patients with hypertension were included and
stratified by cardiovascular risk. We studied the genetic variability of two
genes: the MTHFR gene (C677T) involved in vascular factors and the ACE
gene (I / D) which is part of the renin-angiotensin-aldosterone system.
Results: 33.66% of our population (gender confused) had a higher risk,
40.59% had a medium risk, while 25.75% had a low risk. Concerning the
genetic study, we found an allele frequency (D) of ACE gene of 84.2%
without susceptibility to hypertension whatever the genotype (p = 0.3 and 0.1
genotypes ID and DD, respectively) and a gene frequency (T) of 53.5% of the
MTHFR gene with a statistically significant surisque of homozygous mutant
TT (p = 0.042). 
Conclusion: The D allele of the ACE gene is not correlated with hyper-
tension predisposition while the T allele of the MTHFR gene is associated
with hypertension in its homozygous form.
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Fibromuscular dysplasia (FMD) is a nonatherosclerotic vascular disease
leading to stenosis, aneurysm and dissection, mainly of renal arteries and
carotids. FMD occurs predominantly in females with ~4/1000 prevalence and
cause hypertension, renal ischemia or stroke. The pathogenesis of FMD is
unknown and a genetic origin is suspected given its demonstrated familial
aggregation. We performed whole exome sequencing (WES) in 16 cases
(seven families). Coding variants in 3,971 genes were prioritized on frequency
(minor allele frequency <0.01) and in silico predicted functionality. No gene
harbors variants that are shared among all affected members of at least three
families. Variants from 16 genes of vascular and connective tissue diseases are
excluded as causative in these families. Genes with at least four variants in the
16 patients and vascular genes were followed-up using genotypes from 249
unrelated cases and 689 controls. Gene-based association analyses using
SKAT-O shows nominal significant association with multifocal FMD
(N=164) for myosin light chain kinase (MYLK, P=0.01) previously involved
in thoracic aortic aneurysm, obscurin (OBSCN), a sarcomeric protein
(P=0.003), dynein cytoplasmic heavy chain 1 (DYNC2H1, P=0.02) and
RNF213 previously associated with Moyamoya disease (P=0.01). Our study
indicates genetic heterogeneity and the unlikely existence of a major gene for
FMD and excludes the role of several vascular genes in familial FMD. We
also suggest four possible candidate genes for multifocal FMD, though these
findings need further genetic and functional confirmation. More powerful
WES and association studies (e.g. GWAS) will better decipher the genetic
basis of FMD.
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Women, before menopause, are less affected than men by hypertension and
atherosclerosis, the main causes of cardiovascular diseases. Estrogens have
been shown to protect the vascular endothelium through their nuclear recep-
tors, mainly via the estrogen receptor alpha (ERα). However, recent studies
have shown that a fraction of ERα is located at the cell membrane where it
initiates a Membrane Initiated Steroid Signaling (MISS). Both membrane and
nuclear pathways of ERα play a protective role in endothelial cells but their
respective role in hypertension is unknown. To investigate the protective
effects of ERα in hypertension, we used (i) mice lacking ERα (ERα-/-), (ii)
mice with a point mutation of the palmitoylation site of ERα (C451A-ERα)
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